These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6752290)
41. Langerhans cell induced cytotoxic T-cell responses against normal human epidermal cell targets: in vitro studies. Faure M; Dezutter-Dambuyant C; Schmitt D; Gaucherand M; Thivolet J Br J Dermatol; 1985 Jul; 113 Suppl 28():114-7. PubMed ID: 3160381 [TBL] [Abstract][Full Text] [Related]
42. Hyperthermia for treatment of human split-thickness skin. Differential effects on HLA-DR-expressing cells and keratinocytes. Morhenn VB Transplantation; 1987 Aug; 44(2):280-6. PubMed ID: 3307051 [TBL] [Abstract][Full Text] [Related]
43. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability. Santoli D; Francis MK; Matera L Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933 [TBL] [Abstract][Full Text] [Related]
44. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study. Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303 [TBL] [Abstract][Full Text] [Related]
45. [The interrelation of the expression of HLA class I and II proteins and of the costimulatory proteins CD11a/CD18 and CD16 with the lytic activity of resting and activated natural killer lymphocytes]. Musatov MI; Petrova ED; Konenkov VI Tsitologiia; 1997; 39(7):617-28. PubMed ID: 9490502 [TBL] [Abstract][Full Text] [Related]
46. Loss of HLA-DR expression by human epidermal cells after growth in culture. Hefton JM; Amberson JB; Biozes DG; Weksler ME J Invest Dermatol; 1984 Jul; 83(1):48-50. PubMed ID: 6376639 [TBL] [Abstract][Full Text] [Related]
47. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. Volc-Platzer B; Majdic O; Knapp W; Wolff K; Hinterberger W; Lechner K; Stingl G J Exp Med; 1984 Jun; 159(6):1784-9. PubMed ID: 6202820 [TBL] [Abstract][Full Text] [Related]
48. Immunoelectron microscopic investigation of HLA-DR-positive dendritic cells at the dermo-epidermal junction in skin disorders associated with the deposition of immune complexes. Drijkoningen M; De Vos R; De Wolf-Peeters C; Degreef H; Desmet V Ultrastruct Pathol; 1986; 10(2):123-8. PubMed ID: 3515706 [TBL] [Abstract][Full Text] [Related]
49. Internalization and acidification of surface HLA-DR molecules by epidermal Langerhans cells: a paradigm for antigen processing. Girolomoni G; Cruz PD; Bergstresser PR J Invest Dermatol; 1990 Jun; 94(6):753-60. PubMed ID: 2355180 [TBL] [Abstract][Full Text] [Related]
50. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094 [TBL] [Abstract][Full Text] [Related]
51. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Baker BS; Swain AF; Fry L; Valdimarsson H Br J Dermatol; 1984 May; 110(5):555-64. PubMed ID: 6232938 [TBL] [Abstract][Full Text] [Related]
52. Ultrastructural immunogold labelling of human Langerhans cells enriched epidermal cell suspension. Schmitt D; Faure M; Dezutter-Dambuyant C; Tuffery D Arch Dermatol Res; 1984; 276(1):27-32. PubMed ID: 6367673 [TBL] [Abstract][Full Text] [Related]
53. Rapid purification of human Langerhans cells using paramagnetic microbeads. Simon JC; Dittmar HC; de Roche R; Wilting J; Christ B; Schöpf E Exp Dermatol; 1995 Jun; 4(3):155-61. PubMed ID: 7551563 [TBL] [Abstract][Full Text] [Related]
54. Enrichment of murine and human Langerhans cells with solid phase immunoabsorption using pan-leukocyte monoclonal antibodies. Wood GS; Kosek J; Butcher EC; Morhenn VB J Invest Dermatol; 1985 Jan; 84(1):37-40. PubMed ID: 3880795 [TBL] [Abstract][Full Text] [Related]
55. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Ashworth J; Booker J; Breathnach SM Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268 [TBL] [Abstract][Full Text] [Related]
56. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture. Messadi DV; Pober JS; Murphy GF Lab Invest; 1988 Jan; 58(1):61-7. PubMed ID: 3121914 [TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibodies against human leucocyte antigens. I. Antibodies against beta-2-microglobulin, immunoglobulin kappa light chains, HLA-DR-like antigens, T8 antigen, T1 antigen, a monocyte antigen, and a pan-leucocyte antigen. Horejsí V; Hilgert I; Kristofová H; Bazil V; Bukovský A; Kulhánková J Folia Biol (Praha); 1986; 32(1):12-25. PubMed ID: 2422063 [TBL] [Abstract][Full Text] [Related]
58. Detection of distinct subpopulations of Langerhans cells by flow cytometry and sorting. Vaigot P; Czernielewski J; Prunieras M Cytometry; 1985 Sep; 6(5):422-7. PubMed ID: 2931262 [TBL] [Abstract][Full Text] [Related]
59. Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. Caughman SW; Sharrow SO; Shimada S; Stephany D; Mizuochi T; Rosenberg AS; Katz SI; Singer A Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7438-42. PubMed ID: 3532113 [TBL] [Abstract][Full Text] [Related]
60. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin. Cruchley AT; Speight PM; Williams DM Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]